Document Details
Form
Filing Date
Nov 5, 2024
Document Date
Nov 4, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.
Filer
PRIOR STEPHEN DAVID
